Literature DB >> 19668175

Public biotech 2008--the numbers.

Brady Huggett, John Hodgson, Riku Lähteenmäki.   

Abstract

The sour global economy has left many small public firms gasping for air.

Mesh：

Year:  2009        PMID： 19668175     DOI： 10.1038/nbt0809-710

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  3 in total

1.  Is silence still golden? Mapping the RNAi patent landscape.

Authors:  Per Lundin
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

2.  Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.

Authors:  Thijs J Giezen; Aukje K Mantel-Teeuwisse; Ronald H B Meyboom; Sabine M J M Straus; Hubert G M Leufkens; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

3.  Rethinking Value in the Bio-economy: Finance, Assetization, and the Management of Value.

Authors:  Kean Birch
Journal:  Sci Technol Human Values       Date:  2016-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.